![](/img/cover-not-exists.png)
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases
Covington, Maryanne, He, Xin, Scuron, Monika, Li, Jun, Collins, Robert, Juvekar, Ashish, Shin, Niu, Favata, Margaret, Gallagher, Karen, Sarah, Sarala, Xue, Chu-biao, Peel, Michael, Burke, Krista, OlivVolume:
885
Journal:
European Journal of Pharmacology
DOI:
10.1016/j.ejphar.2020.173505
Date:
October, 2020
File:
PDF, 6.42 MB
2020